<?xml version="1.0" encoding="UTF-8"?>
<ref id="B84-viruses-12-00339">
 <label>84.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Adelfinger</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Bessler</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Frentzen</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Cecil</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Langbein-Laugwitz</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Gentschev</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Szalay</surname>
    <given-names>A.A.</given-names>
   </name>
  </person-group>
  <article-title>Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy</article-title>
  <source>Viruses</source>
  <year>2015</year>
  <volume>7</volume>
  <fpage>4075</fpage>
  <lpage>4092</lpage>
  <pub-id pub-id-type="doi">10.3390/v7072811</pub-id>
  <pub-id pub-id-type="pmid">26205404</pub-id>
 </element-citation>
</ref>
